Patent · US Expired

Compositions and methods for the treatment of inflammatory diseases using topoisomerase inhibitors

US8883856B2 · kind B2 · utility

1Cited by

9References

1Claims

0Family size

Inventors

John Jackson · West Vancouver, CA
Helen Burt · Vancouver, CA
Stephen Dordunoo · Vancouver, CA

Key dates

Filing date	Feb 28, 2001
Grant date	Nov 11, 2014
Priority date	—
Expiry date	Jan 20, 2023

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Topoisomerase inhibitors are useful for the treatment of inflammatory disorders including arthritis, restenosis, surgical adhesions and other diseases. Controlled release polymeric formulations to topoisomerase inhibitors are particularly suitable for this use.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.